Houlihan Lokey Advises VanDeMark Chemical

Houlihan Lokey is pleased to announce that VanDeMark Chemical Inc. (VanDeMark), a portfolio company of Verus Capital Partners (Verus), has been acquired by Comvest Investment Partners Holdings, LLC (Comvest). The transaction closed on April 22, 2019.

Founded in 1951 and headquartered in Lockport, New York, VanDeMark manufactures phosgene and phosgene derivatives used in the pharmaceutical, agricultural, personal care, consumer electronics, paints and coatings, and plastic/polymer end markets. The company is the sole provider of merchant phosgene in North America, and with its European operation, Framochem, based in Kazincbarcika, Hungary, VanDeMark provides innovative niche chemistry that focuses on safety, quality, consistency, timely delivery, and cost.

Verus is a private equity firm focused on buyout and growth capital investments in lower middle-market companies. Based in New York, Verus seeks to partner with management teams where the firm can utilize its collective business experience, relationships, and financial expertise to enhance a company's strategic position and drive profitable growth.

Comvest is a leading middle-market private equity and credit investment firm with more than $3.2 billion in assets under management. Comvest's Private Equity strategy pursues control investments in market-leading companies that can benefit from its strategic and operational guidance to realize their full potential.

Houlihan Lokey served as a sellside advisor to VanDeMark and assisted in the marketing, structuring, and negotiation of the transaction on their behalf. This transaction highlights Houlihan Lokey's strong track record in the global specialty chemicals industry.